期刊文献+

抗高血压药的临床应用

Antihypertensive Drugs in Clinical Application
暂未订购
导出
摘要 目的研究分析抗高血压药物的临床应用情况。方法对我院住院部2010年~2012年抗高血压药物的临床使用情况进行总结,分析各年度抗高血压药物的应用品种、用药金额以及用药频次(DDDs)。结果总体抗高血压药物的销售金额日益上升,高血压药物品种排在前三位的依次是钙通道拮抗剂(CCB)、β受体阻断剂以及血管紧张素转换酶抑制剂(ACEI),单药物用药金额和用药频次在排序中占据前三位的是左旋氨氯地平,硝苯地平缓释片,依那普利。结论我院住院部高血压药物应用最多的品种是CCB类,符合中国高血压防治指南的标准。 Objective To study the analysis of antihypertensive drug clinical application. Methods The clinical data from 2010 to 2012 inpatient department of antihypertensive drug summarize clinical use, this paper analyzes the annual antihypertensive drug application Varieties, amount and drug use frequency (DDDs). Results The overall antihypertensive drug sales amount is increasing day by day, high blood pressure drug varieties the top three in turn is calcium channel antagonists (CCB), beta blockers and angiotensin converting enzyme inhibitors (ACEI), single drug use amount and use frequency in the sorting of the top three is left-handed amlodipine, nifedipine, enalaprilat. Conclusion Our in-patient department high blood pressure drug application most varieties are CCB class, the prevention and control of hypertension guidelines in China standard.
出处 《中国医药指南》 2013年第15期410-411,共2页 Guide of China Medicine
关键词 抗高血压药 用药金额 用药频次 临床应用 Oral antihypertensive drugs Consumption sum DDDs Clinical application
  • 相关文献

参考文献4

二级参考文献25

  • 1陈鲁原,刘同宝,张彤,宋文宣,李自成,李河.国产坎地沙坦酯治疗原发性高血压的随机双盲临床试验[J].中国新药杂志,2004,13(10):930-933. 被引量:11
  • 2张言.血管紧张素转换酶抑制剂的临床应用分析[J].中西医结合心脑血管病杂志,2005,3(2):180-181. 被引量:14
  • 3陈锦华.2003年~2005年我院血管紧张素转换酶抑制剂用药情况分析[J].中国医院用药评价与分析,2007,7(3):202-204. 被引量:2
  • 4黄震华.血管紧张肽受体拮抗药替米沙坦的进展[J].中国新药与临床杂志,2007,26(7):544-548. 被引量:7
  • 5中国高血压防治指南起草委员会.中国高血压防治指南[M].2005修订版.北京:人民卫生出版社,2005:60-61.
  • 6Psaty BM,Heckbert SR,KoepsellTD,et al.The risk of myocardial infarction associated with antihypertensive drug therapies[J].JAMA,1995,274(8):620-625.
  • 7Lichtlen PR,Hugenholtz PG,Rafflenbeul W,et al.Retardation of angiographic progression of coronary artery disease by nifedipine:results of the International Nifedipine Trial on Antiatherosclerotic Therapy (INTACT)[J].Lancet,1990,335(8698):1109-1113.
  • 8Mancini GB,Pitt B.Coronary angiographic changes in patients with cardiac events in the Prospective Randomized Evaluation of the Vascular Effects of Norvasc Trial (PREVENT)[J].Am J Cardiol,2002,90(7):776-778.
  • 9Brown MJ,PalmerCR,CastaigneA,et al.Morbidity and mortality in patients randomised to doubleblind treatment with a long-acting calcium channel-blocker or diuretic in the international Nifedipine GITS study:Interventoin as a goal of hypertension treatment(INSIGHT)[J].Lancet,2000,356(9227):366-372.
  • 10Nissen SE,Tuzcu EM,Libby P,et a1.Effect of antihypertensive agents On cardiovascular events in patients with coronary disease and normal blood pressure.The CAMELOTstudy:a randomized controlled trial[J].JAMA,2004,292(18):2217-2225.

共引文献91

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部